1-12 of 12
pimecrolimus
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Authors’ Response

Bardur Sigurgeirsson, MD, PhD, Thomas Luger, MD
Pediatrics (2015) 136 (5): e1485–e1486.
Published: November 2015
View article
PDF
Journal Articles

Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial

Bardur Sigurgeirsson, MD, Andrzej Boznanski, MD, Gail Todd, FFDerm (SA), André Vertruyen, MD, Marie-Louise A. Schuttelaar, MD ...
Pediatrics (2015) 135 (4): 597–606.
Published: April 2015
View article
PDF
Includes: Supplementary data
Journal Articles

Pediatrics Digest

Pediatrics (2015) 135 (4): D1–D5.
Published: April 2015
View article
PDF
Journal Articles

Off-Label Topical Calcineurin Inhibitor Use in Children

Angelika D. Manthripragada, PhD, Simone P. Pinheiro, ScD, Thomas E. MaCurdy, PhD, Shahin Saneinejad, BA, Chris M. Worrall, BS ...
Pediatrics (2013) 132 (5): e1327–e1332.
Published: November 2013
View article
PDF
Journal Articles

In Reply

Sara K. Pasquali, MD, Danielle S. Burstein, BS, Daniel K. Benjamin, Jr, MD, PhD, P. Brian Smith, MD, MHS, MPH, Jennifer S. Li, MD, MHS
Pediatrics (2011) 127 (1): e253–e254.
Published: January 2011
View article
PDF
Journal Articles

Sustained Efficacy and Safety of Pimecrolimus Cream 1% When Used Long-term (up to 26 Weeks) to Treat Children With Atopic Dermatitis

Audrey Y. Park, MD, PhD, Jonathan M. Spergel, MD, PhD
Pediatrics (2008) 122 (Supplement_4): S199–S200.
Published: November 2008
View article
PDF
Journal Articles

Free Drug Samples in the United States: Characteristics of Pediatric Recipients and Safety Concerns

Sarah L. Cutrona, MD, MPH, Steffie Woolhandler, MD, MPH, Karen E. Lasser, MD, MPH, David H. Bor, MD, David U. Himmelstein, MD ...
Pediatrics (2008) 122 (4): 736–742.
Published: October 2008
View article
PDF
Journal Articles

Long-term Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% in Infants Does Not Interfere With the Development of Protective Antibodies After Vaccination

Jonathan M. Spergel, MD, PhD
Pediatrics (2006) 118 (Supplement_1): S15–S16.
Published: August 2006
View article
PDF
Journal Articles

Efficacy and Tolerability of Pimecrolimus and Tacrolimus in the Treatment of Atopic Dermatitis: Meta-analysis of Randomised Controlled Trials

Wanda Phipatanakul, MD, MS
Pediatrics (2006) 118 (Supplement_1): S16–S17.
Published: August 2006
View article
PDF
Journal Articles

Safety and Tolerability of 1% Pimecrolimus Cream Among Infants: Experience With 1133 Patients Treated for Up to 2 Years

Carle Paul, MD, PhD, Michael Cork, PhD, FRCP, Ana B. Rossi, MD, Kim A. Papp, MD, PhD, FRCPC, Nathalie Barbier, MSc ...
Pediatrics (2006) 117 (1): e118–e128.
Published: January 2006
View article
PDF
Journal Articles

The Benefit of Pimecrolimus (Elidel, SDZ ASM 981) on Parents’ Quality of Life in the Treatment of Pediatric Atopic Dermatitis

Diane Whalley, BSc, Jasper Huels, PhD, Stephen P. McKenna, PhD, Daniel van Assche, PhD
Pediatrics (2002) 110 (6): 1133–1136.
Published: December 2002
View article
PDF
Journal Articles

Efficacy and Safety of Pimecrolimus Cream in the Long-Term Management of Atopic Dermatitis in Children

Ulrich Wahn, MD, Jan D. Bos, MD, Mark Goodfield, MD, Ruggero Caputo, MD, Kim Papp, MD, PhD ...
Pediatrics (2002) 110 (1): e2.
Published: July 2002
View article
PDF